Vascular Surgery Archives

AngioDynamics Releases New DuraFlow 2 Chronic Hemodialysis Catheter

DuraFlow 2 AngioDynamics Releases New DuraFlow 2 Chronic Hemodialysis CatheterAngioDynamics launched in the U.S. its new DuraFlow 2 chronic hemodialysis catheter that allows for higher blood flow over a longer period of time with less recirculation.

Additionally, the soon to be released DuraFlow 2 VascPak (VP) kit has been redesigned to make them smaller for easier handling and storage.

DuraFlow 2 front AngioDynamics Releases New DuraFlow 2 Chronic Hemodialysis Catheter

From the announcement:

Along with the DuraMax® chronic hemodialysis catheter, AngioDynamics offers the only 48 cm chronic dialysis catheters on the market, allowing for femoral catheter placements in patients of varying sizes. The DuraFlow 2 catheter continues to provide optimal ease of insertion and sustained high flow rates. A new tough, rigid thermoplastic polyurethane luer increases durability, allowing for more secure fastening to dialysis machines.

The new streamlined VP kit, set for launch in the fiscal 2012 third quarter, is designed to meet the needs of many outpatient vascular access centers. Additionally, tray sizes for both the VP and basic kits have been reduced by approximately 30 percent, providing an ideal fit with popular automated medical supply stations and easier handling and storage.

Press release: AngioDynamics Launches DuraFlow™ 2 Chronic Hemodialysis Catheter

Boston Sci’s TruePath CTO Crosses Challenging Peripheral Arterial Blockages

Boston Sci's TruePath CTO Crosses Challenging Peripheral Arterial Blockages

Boston Scientific has launched its TruePath CTO Device in the U.S. with a rollout in Europe scheduled for later in the year. TruePath is designed for penetrating through chronic total occlusions that block peripheral arteries, avoiding the need for the patient to undergo a bypass.

The device features a diamond coated tip that can spin at 13,000 rpm to drill right through uncooperative plaque buildups.

Read More

Analogic Releases New BK Medical Ultrasounds

Analogic Releases New BK Medical Ultrasounds

Analogic has announced the worldwide launch of three new ultrasound systems from its subsidiary BK Medical, the Pro Focus UltraView 800, the Flex Focus 800, and the Flex Focus 500.

All three models sport the company’s “Quantum Technology” that provides high resolution visualization of the tissues.

Read More

Bovie J-Plasma Handpiece Greenlighted in U.S.

Bovie J-Plasma Handpiece Greenlighted in U.S.

Bovie Medical received FDA clearance for its J-Plasma handpiece with retractable cutting feature for coagulating soft tissue during surgeries. It is available for both open and laparoscopic procedures.

The device is powered by a previously approved Bovie GS electrosurgical generator.

Read More

HealthStream and Laerdal Unveil New Clinical Simulator Management Tools

HealthStream and Laerdal Unveil New Clinical Simulator Management Tools

HealthStream and Laerdal Medical launched a couple new products for managing and studying clinical simulations.

SimView allows for recording of simulation video, audio, data logs, and how the virtual patient responds to therapy. SimManager is a software-as-a-service (SaaS) application that helps manage simulation routines from scheduling, to progress tracking, to delivering reports while tracking room and equipment availability.

Read More

Philips Unveils Compact Xper Flex Cardio Physiomonitoring

Philips Unveils Compact Xper Flex Cardio Physiomonitoring

Yesterday Philips announced its new Xper Flex Cardio Physiomonitoring system for intraoperative hemodynamic analysis.

The device provides clinicians with Fractional Flow Reserve (FFR) measurements, as well as ECG, respiration, and other vitals. It features both 12 and 16-lead ECG analysis, giving more options when working in the EP, cath labs, and during more invasive procedures.

Read More

Medtronic’s Endurant II AAA Stent Gets EU CE Marking

Medtronic's Endurant II AAA Stent Gets EU CE Marking

Medtronic announced receiving European approval for its Endurant II AAA Stent Graft System and will be making it available globally.

The device provides a minimally invasive (endovascular) option for addressing abdominal aortic aneurysms and includes a few improvements on the previous model:

Read More

Nanotech Coating Could Stop Bleeding within Seconds

Nanotech Coating Could Stop Bleeding within Seconds

A nanoscale biological coating could prevent battlefield deaths by halting bleeding nearly instantaneously. Developed by engineers at MIT with the assistance of Ferrosan Medical Devices A/S (Soeborg, Denmark), the coating includes thrombin, a protein involved in blood clotting that has been used clinically for decades for topical hemostasis and wound management. The coating also contains tannic acid, a molecule found in tea.

In a recent study, the researchers developed a biological coating consisting of two alternating layers sprayed onto a material, such as a sponge. The coating forms a film containing a high level of functional thrombin. According to the researchers, sponges coated with the material can be stored stably and carried by soldiers or medical personnel to treat the wounded. Similar sponges could also prove useful in civilian hospitals.

Read More

Bolton Medical Completes Patient Enrollment in EVAR Trial

Bolton Medical Completes Patient Enrollment in EVAR Trial

Aneurysms of the abdominal aorta have traditionally required an open approach, a high-risk and bloody surgery with a long recovery time. In recent years this practice has been supplanted in certain patient populations by endovascular  aortic repair (EVAR).  In this approach, a graft is introduced into the aorta through the femoral artery, requiring a shorter hospital stay and less blood loss.  One company actively involved in this field is Bolton Medical, based out of Florida and Barcelona.  We last reported on their Treovance Abominal Stent-Graft in May 2011, when the ADVANCE trial of this device first started (link).  Now, patient enrollment has been completed, and the results are reported to be encouraging, although the final data isn’t available yet.

“The Bolton ADVANCE study has been completed and so far the device shows promising results”, said Prof. Roberto Chiesa, Principal Investigator for the ADVANCE Study “I think that the Treovance Abdominal Stent-Graft continues a new generation of devices focused on providing: low-profile systems, precise

Read More